| HOME >> MEDICINE >> TECHNOLOGY |
15,938
94,976 Retained earnings
145,851
124,886 Accumulated other comprehensive income (loss)
40
(36)Total shareholders' equity
161,829
219,826Total liabilities and shareholders' equity
$252,431
$275,808 Questcor Pharmaceuticals, Inc.Consolidated Statements of Cash Flows(In thousands)Years Ended December 31,201220112010(In thousands)Cash Flows From Operating ActivitiesNet income
$197,675
$ 79,591
$ 35,071Adjustments to reconcile net income to net cash provided by operating activities:Share-based compensation expense
15,792
7,326
3,739Deferred income taxes
241
(4,896)
(1,029)Amortization of investments
1,330
1,250
678Depreciation and amortization
1,219
1,044
546Impairment of goodwill and intangibles
987
299
—Loss on disposal of property and equipment
72
11
—Changes in operating assets and liabilities:Accounts receivable
(33,616)
(16,673)
3,705Inventories
(4,683)
(1,500)
(348)Prepaid income taxes
6,940
(3,408)
(3,532)Income taxes payable
7,360
—
—Prepaid expenses and other current assets
(1,509)
(1,527)
(702)Accounts payable
7,566
1,634
(9,052)Accrued compensation
9,710
7,432
2,018Sales-related reserves
3,257
12,608
6,589Other accrued liabilities
6,780
2,526
(255)Other non-current liabilities
(84)
(118)
(871)Net cash provided by operating activities
219,037
85,599
<| SOURCE Questcor Pharmaceuticals, Inc. Copyright©2012 PR Newswire. All rights reserved |